ABOUT IICNA, PC

IICNA, PC, otherwise known as Integrated Infusion Clinics of North America, is the result of extensive study, and review of therapies not commonly available, by Dr. Jerry H. Titel, MD, MBA.

Dr. Titel obtained his medical education from the University of Chicago (Pritzker) Medical School, and then trained as an anesthesiologist.  He researched, taught, and provided anesthesia for decades in various parts of the country.  One of the medications used in anesthesia is Ketamine.  His extensive experience with it stimulated his interest in alternative medical usages for this amazing medication.  Doing so resulted in his gradual expansion into studying other therapies not commonly available, which, in turn, resulted in the creation of IICNA, PC.

Some of the therapies provided are either “off-label” or considered “compassionate”, thus not covered by traditional medical insurances.  Payment will be required at time of service. The clinic offers financing options through outside agencies which may be available depending on individual circumstances. Pricing and payment options will be discussed in detail prior to patient enrollment.

JTitel_profile

IN-CLINIC APPOINTMENTS

Dr. Titel is available to “call-back” in lieu of an informational appointment.  Such “Call-Backs” are charged $300 so please have payment information available.

In-clinic appointments start with an informational appointment during which the clinic’s mission, philosophy, optional therapies, etc. are discussed.  This visit is charged $300 and will last 30-60 minutes.

Should both agree to begin a clinic/patient relationship, an extensive “in-take” visit will follow.  At which time the patients’ medical histories will be reviewed in detail, and appropriate plans for tests, and treatments will follow. This visit is charged $500.  At a minimum, all patients will be evaluated for diabetes, chronic inflammation, and HIV (optional) and microbiome health.  Basic chemistries, vitamin status, amino acid status, hormone status, general blood counts, suicidal ideation and general psychological status will be evaluated. Subsequent laboratory and diagnostic test pricing and follow-up treatment pricing will depend on the individual plans developed. In some cases, insurances may pay for some of the testing.

In addition, as with any therapeutics, no guarantees can be made.

Approaches will be based on both scientific and antidotal information.  Often times, individual patients will have done their own research and request specific therapies.  All therapies will require consents and “contracts” between the parties.